Results 71 to 80 of about 1,004,014 (297)

Report of Workshop on Rehabilitation Centers for the Blind [1961]

, 1961
Sponsored by Division of Services for the Blind, Kansas Department of Social Welfare."The Topeka Workshop while including administrators, was geared to the entire staff or nearly the entire staff of a few centers.
Workshop on Rehabilitation Centers for the Blind (1961 : Topeka, Kan.)
core  

Using Artificial Intelligence-based instructional strategies: An Approach of Responsible Special Education Teaching

Sustainable Business and Society in Emerging Economies
Purpose: The purpose of this study was to examine the use of artificial intelligence-based instructional strategies that are the responsibility of special education teachers.
Kashif Iqbal, Hania Amjad, Samina Ashraf, Irene Glendinning   +3 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Aptamer Selection Technology and Recent Advances

Molecular Therapy: Nucleic Acids, 2015
Over the last decade, aptamers have begun to find their way from basic research to diverse commercial applications. The development of diagnostics is even more widespread than clinical applications because aptamers do not have to be extensively modified ...
Michael Blind, Michael Blank
doaj   +1 more source

Memory and Resting‐State Connectivity in Acute Transient Global Amnesia: A Case–Control fMRI Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Transient global amnesia (TGA) is a striking model of isolated amnesia. While hippocampal lesions are well described, the network‐level mechanisms and the precise neuropsychological profile remain debated. Our objective was thus to characterize functional and neuropsychological correlates of acute TGA and their ...
Elias El Otmani, Emmanuel Barbeau, Béatrice Lemesle, Emilie Milongo‐Rigal, Sophie Fernandez, Sandrine Charpentier, Jean‐François Albucher, Nicolas Raposo, Fabrice Bonneville, Patrice Péran, Jérémie Pariente   +10 more
wiley   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane, Anna Capasso, Chiara Arpaia, Adele D’Amico, Emilio Albamonte, Federica Trucco, Maria Sframeli, Riccardo Masson, Francesca Magri, Luca Bello, Romina Venditti, Claudia Dosi, Michela Catteruccia, Michele Tosi, Claudio Bruno, Sonia Messina, Giacomo Comi, Elena Pegoraro, Valeria A. Sansone, Eugenio Mercuri   +19 more
wiley   +1 more source

Comparative Validation of MOPTIM MRT-200 Refraction Device with 2WIN and Retinomax

Clinical Ophthalmology
Heidi Schumacher,1,2 Giancarlo Garaygay,1 Aana Ayagalria,1 Bryant Ikaika Lauano,1 Denise M Marshall,1,3 J Richard Townley,1,3 Robert W Arnold1 1Alaska Blind Child Discovery, Alaska Children’s EYE & Strabismus, Anchorage, Alaska, 99508, USA; 2Service ...
Schumacher H, Garaygay G, Ayagalria A, Lauano BI, Marshall DM, Townley JR, Arnold RW   +6 more
doaj  

Photo-Oxidation of Various Organic Compounds, Including Pollutants, by Europium (III) in Fuel Cell Systems

ChemEngineering
The ongoing anthropogenic climate crisis necessitates a reassessment of numerous technical domains, including the energy sector. An alternative to conventional fuel cells is provided by photo fuel cells, which possess at least one photoactive electrode ...
Felix Blind, Stefan Fränzle
doaj   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto, Umberto Pensato, Ilaria Casetta, Giorgio U. Marcello, Angelo Barra, Anna Poggesi, Edoardo Carlesi, Sara Mancini, Andrea Ginestroni, Vittorio Miele, Alessandro Padovani, Andrea Morotti, Enrico Fainardi   +12 more
wiley   +1 more source